GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » Revenue

Shanghai INT Medical Instruments Co (HKSE:01501) Revenue : HK$823.4 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai INT Medical Instruments Co Revenue?

Shanghai INT Medical Instruments Co's revenue for the six months ended in Dec. 2023 was HK$451.8 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$823.4 Mil. Shanghai INT Medical Instruments Co's Revenue per Share for the six months ended in Dec. 2023 was HK$2.62. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$4.82.

During the past 12 months, the average Revenue per Share Growth Rate of Shanghai INT Medical Instruments Co was 24.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 23.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 24.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 8 years, Shanghai INT Medical Instruments Co's highest 3-Year average Revenue per Share Growth Rate was 50.00% per year. The lowest was 15.40% per year. And the median was 33.20% per year.


Shanghai INT Medical Instruments Co Revenue Historical Data

The historical data trend for Shanghai INT Medical Instruments Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai INT Medical Instruments Co Revenue Chart

Shanghai INT Medical Instruments Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial 318.76 424.89 568.98 654.26 823.44

Shanghai INT Medical Instruments Co Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 347.83 264.00 402.76 371.63 451.81

Competitive Comparison of Shanghai INT Medical Instruments Co's Revenue

For the Medical Instruments & Supplies subindustry, Shanghai INT Medical Instruments Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai INT Medical Instruments Co's Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai INT Medical Instruments Co's Revenue distribution charts can be found below:

* The bar in red indicates where Shanghai INT Medical Instruments Co's Revenue falls into.



Shanghai INT Medical Instruments Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$823.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai INT Medical Instruments Co  (HKSE:01501) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Shanghai INT Medical Instruments Co Revenue Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai INT Medical Instruments Co (HKSE:01501) Business Description

Traded in Other Exchanges
N/A
Address
No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803
Shanghai INT Medical Instruments Co Ltd formerly Shanghai Kindly Medical Instruments Co Ltd is a manufacturer of cardiovascular interventional devices, which are mainly used in cardiovascular surgeries, and in particular, PCI procedures in China. It is engaged in the sales, manufacture, research, and development of cardiovascular interventional medical devices as well as related accessories and molds. It is also engaged in the research and development of other interventional and implantable medical devices, such as neurological interventional medical devices and endocardia implantable medical devices, among others. Geographically, it has operations in Mainland China, Europe, the United States, and Other countries.
Executives
China Orient Asset Management (international) Holding Limited 2201 Interest of corporation controlled by you
Jpmorgan Chase & Co. 2106 Person having a security interest in shares
Zhao Wei 2202 Interest of your spouse
Ningbo Huaige Gongxin Equity Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Ningbo Huaige Health Investment Management Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Ningbo Huaige Taiyi Equity Investment Partnership (limited Partnership) 2101 Beneficial owner
Wang Kai 2201 Interest of corporation controlled by you
Zhao Wei 2202 Interest of your spouse
Shanghai Gongye Investment Co., Ltd. 2201 Interest of corporation controlled by you
Zhang Wei 2501 Other
Worldwide Healthcare Trust Plc 2101 Beneficial owner
Orbimed Capital Llc 2102 Investment manager
Zheng Aiping 2501 Other
Zhang Xianmiao 2501 Other
Zhang Wei 2501 Other

Shanghai INT Medical Instruments Co (HKSE:01501) Headlines

No Headlines